Series B Biotechnology Companies

Terrana's innovative technology platform uses RNA-based plant health solutions to enable resilient agriculture for a world.

Actio Biosciences is a research center that develops drugs for rare diseases.

Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.

Salvia BioElectronics develops neuromodulation devices for migraine treatment and management.

GlycoEra is a biotechnology research company that produces extracellular protein degraders for the treatment of autoimmune diseases.

Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.

TILT Biotherapeutics Ltd is the leading company globally working in the area of enabling tumor.

Azafaros aims at developing new therapeutic agents for the treatment of rare metabolic disorders.

Nuevocor operates as a preclinical-stage biotech company.

Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.

Transverse Medical is a medical equipment manufacturing company.

Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.

Ace Vision Group develop laser-based therapeutic technologies to heal age-related eye dysfunction and restore the eye's natural performance.

BioLumic unlocks the natural genetic potential of seeds and seedlings with specialized light treatments, data science, and technology.

PhotoPharmics is a medical device company that develops treatments for treating neurodegenerative disorders.

KAICO is a biotechnology company that provides hard-expressing proteins to develop drugs with a silkworm-baculovirus expression system.

Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.

Medical AI company with a focus on critical care.

Epic Bio's strength is a relentless focus on ushering in a new era of gene regulation.

Tempero Bio develops treatments for Substance Use Disorders as a clinical-stage biopharmaceutical company.

Ampersand Biomedicines is a multi-product platform that develops programmable medicines that target disease sites precisely.

Gallant is advancing investigational stem cell therapies to help give pets more good years, making regenerative care more accessible.

Neuromod Devices has developed LENIRE® (www.lenire.com) a non-invasive bimodal neuromodulation therapy for tinnitus.

Osivax is a clinical stage biotechnology company developing a pipeline of vaccines and immunotherapies.

EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.